MD Medical Group signs cooperation agreement with Sberbank
|Download file (218 K)|
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has signed a strategic cooperation agreement with Sberbank as part of the development of Russia’s first nationwide healthcare marketplace shop.docdoc.ru.
Under the agreement, MD Medical Group will provide its healthcare services via a new online platform which is part of Sberbank Group in the following areas: medical check-up, pre-natal and post-natal care, oncology and cardiovascular disease treatment.
Patients will be able to use the services via telemedicine from their homes or offices, or make an appointment with a specialist at one of the facilities in MDMG’s growing network in 18 Russian regions. The services will also be available under the Voluntary Healthcare Insurance programme.
The Group has already cooperated with Sberbank in other areas. In 2017, the bank’s branches in Moscow, Ufa and Yaroslavl launched sales of MDMG’s medical check-up programmes. Thanks to its work with the largest bank in Russia, whose services are used by 70% of the country’s population, the Group is able to reach a wide customer base.
Mark Kurtser, CEO of MD Medical Group, said:
“We are pleased to partner with Sberbank. Cooperation with this major nationwide financial platrform will provide our existing and new patients across Russia with an innovative way to access our high-quality services.“As a leading multi-disciplinary player on the private healthcare market in Russia, we will use the marketplace to offer both our core medical services for women and a wider range of services for all family members.“With our significant experience and developed network of hospitals and clinics in 18 regions across Russia, we are well-positioned to satisfy the needs of patients in close proximity to where they live. At the same time, to provide an even greater level of convenience, we will be offering telemedicine services, thus leveraging the newest trend on the healthcare market.”
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 4120
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 35 modern healthcare facilities, including 5 hospitals and 30 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, and Voronezh.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2018 2017 2016 2015 2014 2013 2012